Back to MW MARSHALL WACE, LLP

TENXTENX
4 quarters

Position history for MWMARSHALL WACE, LLP's holdings in Tenax Therapeutics, Inc.

MARSHALL WACE, LLP holds 585,578 shares of TENX (Tenax Therapeutics, Inc.), worth $8.5M as of 2026-Q2. The position was increased (+66.1% shares). TENX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$8.5M

Current Shares

585,578

Total Value Change

+$7.2M

Total Shares Change

+408,369

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
585,578
+66.1%
$8.5M0.0%$14.55
40
2026-Q1
Increased
352,572
+18.3%
$5.6M0.0%$11.42
32
2025-Q4
Increased
298,153
+68.3%
$3.6M0.0%$12.00
39
2025-Q3
New
177,209
-
$1.3M0.0%$7.28
35

Other major holders of TENX: FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Janus Henderson Group Ltd., BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used